Circassia is an AIM listed speciality pharmaceutical company focused on respiratory disease with UK Corporate Headquaters at The Oxford Science Park
OrganOx is an Oxford-based MedTech business founded in 2008 as a spin-out from the University of Oxford to advance the normothermic perfusion technology
Oxford BioMedica (OXB) is a leading gene and cell therapy group focused on developing life changing treatments for serious diseases.
Oxford Nanopore Technologies is a private company that develops disruptive, electronic, single-molecule sensing system based on nanopore science.
The company’s high-tech factory was opened on Harwell Campus in 2019 to cater for the accelerating demand for its sequencing products.
About Oxford PharmaGenesis Oxford PharmaGenesis is an award-winning HealthScience communications consultancy providing services to the healthcare industry, professional societies and patient groups through our specialist…
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.